Pyridazinone compounds and their use as DAAO inhibitors
US11129828B2 · kind B2 · utility
1Cited by
13References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2019 |
| Grant date | Sep 28, 2021 |
| Priority date | — |
| Expiry date | Sep 24, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/0812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.